News
SNOA
0.1539
-1.72%
-0.0027
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday's pre-market session. 23andMe Holding stock moved upwards by 26.61% in the pre- market session. NRX Pharmaceuticals shares declined by 22.5% during the session.
Benzinga · 1d ago
Weekly Report: what happened at SNOA last week (0408-0412)?
Weekly Report · 4d ago
Sonoma Pharmaceuticals Presents Business and Financial Update
TipRanks · 04/09 11:42
Sonoma Pharmaceuticals Announced The Expansion Of Its Microcyn Negative-pressure Wound Therapy (NPWT) Solution Products In The U.S.
Microcyn Negative-Pressure Wound Therapy Solution is now available in convenient sizes of 250ml, 450ml, and 990ml. Sonoma's solution delivers optimal wound cleansing and management, promoting faster healing and improved patient outcomes. It does not contain antibiotics and does not promote antibiotic resistance.
Benzinga · 04/09 11:35
SONOMA PHARMACEUTICALS INC: ANNOUNCED EXPANSION OF ITS MICROCYN® NEGATIVE-PRESSURE WOUND THERAPY (NPWT) SOLUTION PRODUCTS IN UNITED STATES
Reuters · 04/09 11:34
Weekly Report: what happened at SNOA last week (0401-0405)?
Weekly Report · 04/08 10:43
Sonoma Pharmaceuticals Outlines Growth and Challenges
TipRanks · 04/02 11:42
Weekly Report: what happened at SNOA last week (0325-0329)?
Weekly Report · 04/01 10:42
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. Xilio Therapeutic (XLO) stock moved upwards by 223.94% during the session. Akanda (AKAN) shares increased by 27.1% and INVO Bioscience (INVO) stock increased by 16.36%. NuCana (NCNA) stock declined by 19.8% in the pre- market.
Benzinga · 03/28 12:06
Sonoma Pharmaceuticals Highlights Safety Advantages Of Microcyn Products
Sonoma Pharmaceuticals, Inc. Highlights the safety advantages of its Microcyn technology products in response to concerns related to benzoyl peroxide. The company is a global healthcare leader developing and producing patented MicrocyN technology based stabilized hypochlorous acid products.
Benzinga · 03/27 11:37
Weekly Report: what happened at SNOA last week (0318-0322)?
Weekly Report · 03/25 10:44
Weekly Report: what happened at SNOA last week (0311-0315)?
Weekly Report · 03/18 10:42
Weekly Report: what happened at SNOA last week (0304-0308)?
Weekly Report · 03/11 10:40
Weekly Report: what happened at SNOA last week (0226-0301)?
Weekly Report · 03/04 10:43
Weekly Report: what happened at SNOA last week (0219-0223)?
Weekly Report · 02/26 10:52
Weekly Report: what happened at SNOA last week (0212-0216)?
Weekly Report · 02/19 10:54
Weekly Report: what happened at SNOA last week (0205-0209)?
Weekly Report · 02/12 10:45
Sonoma Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $3.14M misses by $0.62M
Earnings News Sonoma Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $3.14M misses by $ 0.62M. Shares -2% AH. Q3 GAAP earnings of $1.07 per share.
Seeking Alpha · 02/08 22:22
Sonoma Pharmaceuticals Q3 EPS $(0.08) Up From $(0.62) YoY, Sales $3.14M Up From $2.94M YoY
Sonoma Pharmaceuticals reported quarterly losses of $0.08 per share. The company reported $3.14 million in sales this quarter. This is a 6.59 percent increase over sales of $2.94 million from the same period last year. The drug company also reported a 87.1 percent increase in sales.
Benzinga · 02/08 21:44
Weekly Report: what happened at SNOA last week (0129-0202)?
Weekly Report · 02/05 10:52
More
Webull provides a variety of real-time SNOA stock news. You can receive the latest news about Sonoma Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About SNOA
Sonoma Pharmaceuticals, Inc. is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. The Company's product offerings include Regenacyn Advanced Scar Gel, Regenacyn Plus Scar Gel, Rejuvacyn Advanced Skin Repair Cooling Mist, Pediacyn Skin Care, Microcyn, Ocucyn Eyelid and Eyelash Cleanser, Microdacyn60 Oral Care, Podiacyn Advanced Everyday Foot Care, and MicrocynAH. Regenacyn Advanced Scar Gel helps to improve the overall appearance of scars while reducing pain, itch, redness, and inflammation. Regenacyn Plus is a prescription-strength scar gel which is available as an office dispense product through dermatology practices and medical spas. Pediacyn is a pediatric dermatology and wound care product for over-the-counter use. MicrocynAH is a HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.